Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2379 of 5804
-
Could an infrared hat tame epilepsy seizures?
Symptom relief Recruiting nowDrug-resistant epilepsy represents roughly 40% of people with epilepsy. It is very challenging to stop seizures in this condition, and the treatment options are limited. This study aims to investigate a new treatment that involves using infra-red light. In animals, this treatment…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New device aims to quiet an overactive bladder without drugs
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a vaginal radiofrequency (RF) device called MORPHEUSV works to treat overactive bladder (OAB) in women. Researchers also want to learn how safe the device is for this indication. This study will include women ages 22 to 80 who have h…
Phase: NA • Sponsor: InMode MD Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Ant venom allergy treatment: does it last?
Knowledge-focused Recruiting nowJack Jumper ant (JJA) venom allergy is a uniquely Australian medical condition. It is the leading cause of venom allergy and affects up to three per cent of the population. 70 percent of people with JJA allergy will have another reaction on a repeat sting and this sensitivity app…
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Could ritalin help kids with sickle cell disease? new pilot trial launches
Symptom relief Recruiting nowThe purpose of this study is to determine if patients with sickle cell disease (SCD) can consistently take a drug called Methylphenidate (MPH) daily, once a day for 4 weeks to help with any thinking, attention or schoolwork problems and if they have any side effects. The study w…
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Sleep therapy trial aims to ease mental distress in hong kong youth
Symptom relief Not yet recruitingThis cluster randomized controlled trial (cRCT) aims to evaluate the effectiveness of a Cognitive Behavioral Therapy for Insomnia (CBTi) intervention in enhancing sleep quality, overall quality of life, functional ability, and reducing mental distress among at-risk youths in Hong…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New drug stapokibart aims to ease stuffy nose in Non-Allergic rhinitis
Disease control Not yet recruitingThe goal of this clinical trial is to learn if Stapokibart (CM310) works to treat Non-Allergic Rhinitis with Eosinophilia Syndrome (NARES) in adults. It will also learn about the safety of CM310. The main questions it aims to answer are: Does drug CM310 relieve the symptoms of …
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New mRNA drug takes on HER2 cancers in first human trial
Disease control Recruiting nowThis clinical trial is designed to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of MT-304 in adults with advanced HER2-expressing solid tumors. The main questions it aims to answer are: * What is the safety profile of MT-304 when administered…
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New study tracks psoriasis Drug's Real-World impact on diverse skin types
Knowledge-focused Recruiting nowThis is a multi-centre, non-interventional, open-label, prospective observational study that will be conducted across Canada over 52-week duration. Approximately 80 patients who are initiating tildrakizumab as part of their routine care through the ILUMYA SUPPORT® Program and mee…
Sponsor: Chronicle Academy • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Ear seeds and steroids: a new combo to beat chemo sickness?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if auricular point stimulation plus dexamethasone works to effectively prevent or suppress nausea and vomiting caused by docetaxel combined with cyclophosphamide in breast cancer adjuvant chemotherapy. It will also learn about the safet…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Ear seeds and steroids: a new combo to fight chemo nausea?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if auricular point stimulation plus dexamethasone works to effectively prevent or suppress nausea and vomiting caused by trastuzumab deruxtecan in breast cancer palliative therapy. It will also learn about the safety and influence on ga…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Smart inhalers and video visits could transform Kids' asthma care
Disease control Recruiting nowThis pilot study aims to explore whether a digital approach to managing childhood asthma using connected inhalers and video consultations triggered by alerts from these devices - could work as well as standard in-person care. The connected inhalers track when children use their d…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a Man-Made bone putty replace your own bone in ankle surgery?
Disease control Recruiting nowThis is a phase IV post-marketing study for MagnetOs Putty and MagnetOs Easypack Putty. MagnetOs is a synthetic bone graft extender product that is routinely used by surgeon as treatment for hindfoot and ankle disorders. In this study, MagnetOs Putty and MagnetOs Easypack Putty …
Phase: NA • Sponsor: Kuros Biosurgery AG • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Eco-Diet trial aims to slash heart risk in Middle-Aged adults
Disease control Recruiting nowThis study aims to investigate the effects of sustainable diets on traditional and novel cardiometabolic risk factors. The primary objective is: • To test the effects of a sustainable diet on traditional cardiometabolic risk factors, specifically, a metabolic health score. The…
Phase: NA • Sponsor: University of Copenhagen • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Iron infusions may ease POTS symptoms in small trial
Symptom relief Recruiting nowPeople with postural orthostatic tachycardia syndrome (POTS) often have low red blood cell volumes and low ferritin in their blood (a marker of iron storage in the body). The purpose of this pilot study is to investigate whether giving iron to people with POTS who have low ferrit…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Can a COPD inhaler also help your heart?
Disease control Recruiting nowThe purpose of the study is to evaluate the effect of BGF MDI compared with placebo MDI on cardiac and lung function when administered in participants diagnosed with COPD and hyperinflation.
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can stem cell exosomes boost laser hair regrowth? new trial aims to find out.
Disease control Not yet recruitingThis trial aims to evaluate the efficacy, safety, and tolerability of fractional laser combined with topical exosome for hair regrowth in patients with androgenetic alopecia. This study is expected to recruit 30 participants. The experimental group will receive fractional laser …
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can a home balance game boost brain and body in MS?
Symptom relief Recruiting nowThe study involves a two-arm, Phase 1, randomized controlled clinical trial designed to establish the feasibility and effects of a Functional Balance Intervention (FBI) on physical and cognitive function, as well as measures of daily living among persons with multiple sclerosis (…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Sound therapy shows promise for fibromyalgia distress
Symptom relief CompletedThis study tests whether different types of sounds can help reduce emotional distress in people with fibromyalgia. Fibromyalgia is a condition that causes widespread muscle and joint pain and makes people extra sensitive to sounds and other sensations. Many people with fibromyalg…
Phase: NA • Sponsor: Universidad de Granada • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New hope for advanced cancer? early trial of BC2027 begins
Disease control Recruiting nowThis is a phase Ia/Ib, open-label, dose escalation and dose expansion study designed to evaluate the safety, tolerability, PK, and preliminary anticancer activity of BC2027 in patients with advanced solid Malignanciesr
Phase: PHASE1 • Sponsor: Biocity Biopharmaceutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New surgery aims to fix reflux after Weight-Loss bypass
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy of fundoplication with stomach excluded in the suppression of disabling gastroesophageal reflux requiring surgery in patients who have undergone one anastomosis gastric bypass, with complete objective evaluation of reflux.
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC